Home
BCRX
BCRX News

Latest BioCryst Pharmaceuticals Inc. (BCRX) News on September 14, 2024

BlackRock Inc. Expands Stake in BioCryst Pharmaceuticals

GuruFocus.com

3 days ago

BlackRock Inc. Expands Stake in BioCryst Pharmaceuticals

BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium

GlobeNewswire

9 days ago

BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium

BioCryst Appoints Dr. Donald Fong Chief Medical Officer

GlobeNewswire

9 days ago

BioCryst Appoints Dr. Donald Fong Chief Medical Officer

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 days ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

High Growth Tech Stocks To Watch In August 2024

Simply Wall St.

16 days ago

High Growth Tech Stocks To Watch In August 2024

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire

23 days ago

BioCryst to Present at Upcoming Investor Conferences

BioCryst Pharmaceuticals (BCRX) Q2 2024 Earnings Call Transcript

Motley Fool

a month ago

BioCryst Pharmaceuticals (BCRX) Q2 2024 Earnings Call Transcript

Can BioCryst (BCRX) Climb 99.43% to Reach the Level Wall Street Analysts Expect?

Zacks

a month ago

Can BioCryst (BCRX) Climb 99.43% to Reach the Level Wall Street Analysts Expect?

BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a month ago

BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates

MT Newswires

a month ago

BioCryst Pharmaceuticals Q2 Adjusted Loss Narrows, Revenue Rises

Associated Press Finance

a month ago

BioCryst: Q2 Earnings Snapshot

BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a month ago

BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?

Zacks

a month ago

Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

Zacks

2 months ago

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

BioCryst to Report Second Quarter 2024 Financial Results on August 5

GlobeNewswire

2 months ago

BioCryst to Report Second Quarter 2024 Financial Results on August 5

BioCryst (BCRX) Upgraded to Strong Buy: Here's Why

Zacks

2 months ago

BioCryst (BCRX) Upgraded to Strong Buy: Here's Why

Wall Street Analysts See a 92.57% Upside in BioCryst (BCRX): Can the Stock Really Move This High?

Zacks

2 months ago

Wall Street Analysts See a 92.57% Upside in BioCryst (BCRX): Can the Stock Really Move This High?

BioCryst Pharmaceuticals' (NASDAQ:BCRX) growing losses don't faze investors as the stock spikes 18% this past week

Simply Wall St.

2 months ago

BioCryst Pharmaceuticals' (NASDAQ:BCRX) growing losses don't faze investors as the stock spikes 18% this past week

ORLADEYO gains approval in Peru for HAE prevention

Pharmaceutical Technology

2 months ago

ORLADEYO gains approval in Peru for HAE prevention

MT Newswires

2 months ago

BioCryst Pharmaceuticals Says Orladeyo Approved in Peru

ORLADEYO® (berotralstat) Approved in Peru

GlobeNewswire

2 months ago

ORLADEYO® (berotralstat) Approved in Peru

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings

Simply Wall St.

3 months ago

BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/14/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/13/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/12/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/11/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/10/2024

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

3 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

3 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

3 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

3 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

3 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

3 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

3 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

3 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

3 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

3 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

GuruFocus.com

3 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

VanEck Semiconductor ETF Is Riskier Than You Think

Motley Fool

3 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Motley Fool

3 months ago

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Reuters

3 months ago

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Simply Wall St.

3 months ago

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

GuruFocus.com

3 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/07/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/06/2024

Most Shareholders Will Probably Agree With BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) CEO Compensation

Simply Wall St.

3 months ago

Most Shareholders Will Probably Agree With BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) CEO Compensation

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/05/2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/04/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 06/03/2024

MT Newswires

3 months ago

BioCryst Pharmaceuticals Says Drug Shows Evidence of Reducing Attacks Among Hereditary Angioedema Patients

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment

GlobeNewswire

3 months ago

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 05/31/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 05/30/2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future

Simply Wall St.

4 months ago

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/29/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/28/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/24/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/23/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/22/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/21/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/20/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/17/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 05/16/2024

MT Newswires

4 months ago

BioCryst Pharmaceuticals Shares Rise 20% Following Disclosure of Executive Share Purchases

Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...

GuruFocus.com

4 months ago

Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...

Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)

GuruFocus.com

4 months ago

Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)

Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)

GuruFocus.com

4 months ago

Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)

Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)

GuruFocus.com

4 months ago

Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

GlobeNewswire

4 months ago

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

MT Newswires

4 months ago

BioCryst Says Orladeyo Granted Approval in Mexico

ORLADEYO® (berotralstat) Approved in Mexico

GlobeNewswire

4 months ago

ORLADEYO® (berotralstat) Approved in Mexico

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)

GlobeNewswire

4 months ago

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results

Simply Wall St.

4 months ago

Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results

MT Newswires

4 months ago

JMP Securities Adjusts Price Target on BioCryst Pharmaceuticals to $15 From $14, Maintains Market Outperform Rating

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript

Insider Monkey

4 months ago

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire

4 months ago

BioCryst to Present at Upcoming Investor Conferences

BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

4 months ago

BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

4 months ago

BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...

Thomson Reuters StreetEvents

4 months ago

Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call

Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday

Motley Fool

4 months ago

Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance

Benzinga

4 months ago

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

Motley Fool

4 months ago

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

Associated Press Finance

4 months ago

BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024

Associated Press

4 months ago

BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Tuesday, 5/6/2024

MT Newswires

4 months ago

BioCryst Pharmaceuticals Shares Jump After Q1 Beat

BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts

GuruFocus.com

4 months ago

BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates

Zacks

4 months ago

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

4 months ago

BioCryst: Q1 Earnings Snapshot

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know

Zacks

4 months ago

Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know

BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

5 months ago

BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing

Simply Wall St.

5 months ago

With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing

BioCryst to Report First Quarter 2024 Financial Results on May 6

GlobeNewswire

5 months ago

BioCryst to Report First Quarter 2024 Financial Results on May 6

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

GlobeNewswire

5 months ago

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

12 Best Depressed Stocks To Buy in 2024

Insider Monkey

5 months ago

12 Best Depressed Stocks To Buy in 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share on Social Networks: